Apparently, it’s not just me. I’m probably like most buyers of products or services, especially those in high tech. Watching a video of some other person using or demonstrating a

Clinical AI startup Abridge is one of the most well-funded health tech startups in the nation, having raised $1.1 billion since its founding in 2018. On Thursday, the startup held

A Novartis RNA therapy reduced blood levels of a protein that’s a biological indicator of a particular form of muscular dystrophy, clinical trial results that could support an application seeking

Value-based care (VBC) goals include better outcomes and sustainable reimbursement. But it won’t work if organizations can’t accurately attribute patients, providers, and encounters across an increasingly complex ecosystem. Many healthcare

The Digital Medicine Society (DiMe) unveiled a new initiative on Tuesday during the AHIP 2026 Conference that aims to create best practices for contracting with virtual care providers. DiMe is

If you want to know where healthcare finance is headed, ask the people who lend hospitals money.  During a Tuesday panel at the HFMA Annual Conference in National Harbor, Maryland,

Health insurers are keen to assess the value and effectiveness of AI applications across different parts of their businesses. But in which areas is their attention focused? What does success

CMS Administrator Dr. Mehmet Oz is optimistic about Washington’s ability to bend the healthcare cost curve, he said during a Tuesday address at the HFMA Annual Conference in National Harbor,

GSK’s oncology strategy had focused on gynecological and blood cancers, but the pharmaceutical company is striking deals that broaden its scope. It’s making a big move in lung cancer, announcing

For severe cases of the bleeding disorder von Willebrand disease, patients must make frequent visits to treatment centers for infusions of the key clotting protein that they lack. Incyte is